Andreas Lindauer is a Senior Consultant at SGS Exprimo. He was born in 1980 in Germany and studied pharmacy at the University at Bonn where he obtained his license in 2006. Thereafter he started his PhD research at the Department of Clinical Pharmacy at the same university, focusing on the PK/PD modelling in oncology and the CNS. He completed his research with his thesis entitled: “Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Biomarker Response to Venlafaxine and Sunitinib Admin-istration”. In 2009, he moved to Barcelona where he joined Ferrer Internacional, as a pharmacometrician in the Department of Drug Metabolism and Pharmacokinetics. At Ferrer he was mainly working on the development of anti-infective agents and drugs for the treatment of sleep disorders. In 2011, Andreas joined Merck, Sharp & Dohme in Oss, The Netherlands. There he worked in several multi-disciplinary clinical development teams (early stage) where he was responsible for the planning and conduct of PK/PD and M&S related activities. In addition he performed M&S analysis in several therapeutic areas including oncology, CNS, infectious diseases, cardiovascular diseases and hematology. Andreas joined Exprimo in 2014 and lives in Spain.